Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial.
about
Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing lossThe 1st and the 2nd Italian Consensus Conferences on low-density lipoprotein-apheresis. A practical synopsis and updateInner ear symptoms and disease: pathophysiological understanding and therapeutic optionsLipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selectionEndothelial Dysfunction in Idiopathic Sudden Sensorineural Hearing Loss: A ReviewGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Prognostic impact of standard laboratory values on outcome in patients with sudden sensorineural hearing lossTherapy of hearing disorders - conservative procedures.Perspectives on the pathophysiology and treatment of sudden idiopathic sensorineural hearing lossRheopheresis in treatment of idiopathic sensorineural sudden hearing loss.Fibrinogen apheresis in the treatment of peripheral arterial disease.Lipid-apheresis improves microcirculation of the upper limbs.The HELP system for the treatment of atherothrombotic disorders: a review.Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and in apparently healthy peopleState of the art of low-density lipoprotein apheresis in the year 2003.HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures.Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss.Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signalingPredictors of hearing recovery in patients with severe sudden sensorineural hearing loss.Therapeutic apheresis--state of the art in the year 2005.Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss.A clinical study of serum lipid disturbance in Chinese patients with sudden deafness.Platelet glycoproteins and fibrinogen in recovery from idiopathic sudden hearing loss.Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: review of rationale and preliminary report.Lipid apheresis, indications, and principles.The selective therapeutic apheresis procedures.Intratympanic steroids as a salvage treatment for sudden sensorineural hearing loss? A meta-analysis.Laboratory assessment of sudden sensorineural hearing loss: A case-control study.Italian multicenter study on low-density lipoprotein apheresis Working Group 2009 survey.The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial.Therapeutic apheresis in peripheral and retinal circulatory disorders.Methylenetetrahydrofolate reductase C677T gene mutation as risk factor for sudden sensorineural hearing loss: association with plasma homocysteine, folate and cholesterol concentrations.Role of H.E.L.P.-apheresis in the treatment of sudden sensorineural hearing loss in a group of 230 patients.Idiopathic sudden sensorineural hearing loss: classic cardiovascular and new genetic risk factors.Influence of lipoproteins and fibrinogen on pathogenesis of sudden sensorineural hearing loss.Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation in the peripheral venous blood: a model in hypercholesterolaemic patients.The efficacy and safety of the new heparin-induced extracorporeal low-density lipoprotein precipitation system (Plasmat Futura) in comparison with the currently used system (Plasmat Secura).Comparative analysis between dextran sulfate adsorption and direct adsorption of lipoproteins in their capability to reduce erythrocyte adhesiveness/aggregation in the peripheral blood.A clinical study of microcirculatory disturbance in Chinese patients with sudden deafness.The influence of cholesterol on the motility of cochlear outer hair cells and the motor protein prestin.
P2860
Q24240130-ACD3DA54-284A-4D54-ACF3-21C61B5A8F18Q26740292-E45CF5C9-2DA1-4219-BE1D-02E0F1FA1AC6Q26997318-7047D51F-2579-467A-8CD3-2DB5918805C4Q28078664-2E0F7D8E-F517-4E9D-9717-E7A24D2A4562Q28078738-80E8059C-FA41-4BE7-9A2D-9DE14B0B3A5CQ30276550-198E4D1A-9E74-4E79-9F82-4824A2EB6D53Q30434745-5D973E84-159B-4DFE-B3BB-6278A97A0132Q30473039-CED54BA7-CB0B-429C-9BCC-7A4676BB508CQ30485146-307C3B07-4803-4EB8-A291-240BC55BB8BAQ32178393-94F7645D-CB68-49D6-9F47-0E39218AC75DQ33300662-44A3A506-07A6-4109-AD54-067D862C09FFQ33875391-96329993-7350-440E-894A-4C006CF3371AQ35187607-FC9C5C92-573E-4C36-A7F6-16892415971BQ35582098-465383C2-DDCF-4C85-AA62-4A60D54D8B5BQ35837148-9141D7C1-A30C-436E-9437-9B95DC9AEC20Q36028557-6A37C976-81BC-4502-BB35-E24183DEF03CQ36028599-5B6E4509-EEF0-4337-B4F9-F8F99E4DD4AEQ36115170-299A49AE-77E4-49A6-A13B-0100F81F1617Q36335026-95EC7C0A-9A3E-4925-9127-9C988A61F22EQ36341821-F9134388-D997-492E-9F41-FDDD9381CF06Q36939363-556E87FF-069F-4C58-A22F-43220FA84256Q37028501-2DE0AB59-84E6-4A2F-94F6-495AD1CE6503Q37510585-16A38A7C-7056-474A-B9D7-0B10FC2ED7DCQ37640171-637424FD-E0DC-4F33-9EF5-4535956C8AD3Q37915431-C2006CC8-8643-482A-82C3-1E83753F0F08Q38082734-2ED81552-4377-42BA-B414-2DC29C6AFAC5Q38248769-B35A0BD5-E33D-48F6-BE33-2CE745E12BC6Q38948695-6858CE10-AF48-43DA-A005-EFCCA8BBDF8EQ39229652-733146B3-F28E-419E-9814-632A98D0FC70Q41130951-828D751E-C168-43B6-9875-A1C90FB9EB99Q42141780-F81350F7-A55C-42E5-92FF-1C6D7EAEAB70Q43056915-92236EB3-6694-4E54-AB37-669AD33BA02AQ43071551-C91898E3-9468-4888-9096-2ECBC9D97492Q44185679-FAA96C9C-1597-4FE6-9524-4A1699D6BAA2Q44393510-00EAA9E1-40E9-4A5B-9026-A231F61D0E93Q44667848-77CFFB34-5402-4525-88A7-3A0D682BBD2AQ44884393-8E827A05-78C9-4957-8C97-7B51E0D50F7EQ44884396-0B098BEB-64C7-4678-B7C1-0A3A0D9D7C69Q46109926-82C9903D-8D0D-4A21-AE11-FDDB60B005E8Q46157009-E601D171-DC2A-4F1B-9014-0CF745D89401
P2860
Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@ast
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@en
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@nl
type
label
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@ast
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@en
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@nl
prefLabel
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@ast
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@en
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@nl
P1433
P1476
Fibrinogen and LDL apheresis i ...... randomised multicentre trial.
@en
P2093
Hearing Loss Study Group
M Suckfüll
P304
P356
10.1016/S0140-6736(02)11768-5
P407
P577
2002-12-01T00:00:00Z